Company
New York, OS
Every investor coverage indicates participated in a round Nasdaq raised.
Companies Nasdaq acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Nasdaq. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Melbourne pharma Clinuvel is weighing a restructure into a US holding company listed only on Nasdaq and an ASX exit, weeks after completing a Nasdaq ADS uplisting, alongside a tenth straight annual profit.
AFR cybersecurity topic page rounding up recent stories: Origin Energy's data breach investigation, Point Wild's planned ASX float, AI models hacking companies, and a CyberCX–Monash University cybersecurity degree partnership.
The head of neo-cloud firm Sharon AI argues no copyright change is needed to attract data centre investment; the piece recalls its Nasdaq listing raise and a large new financing.
Trading platform eToro has finalised its long-stalled Nasdaq debut, with shares priced near the top of guidance; users see no immediate change, though quarterly public disclosures now apply.
KPMG administrators have taken control of Australian solar thermal developer Vast Renewables and will run a sale or recapitalisation process, following its recent Nasdaq delisting; the Port Augusta project's future is unclear.
Australian data governance company RecordPoint has launched RexCommand, a free platform helping startups detect unauthorised AI tool use and enforce AI policies, with CEO Anthony Woodward warning about shadow AI risks for businesses.
Opinion piece on the buzz around a musical number promoting Canva's enterprise offering at its Los Angeles event, noting cofounder Cliff Obrecht's approval, huge viewership and the company's US listing ambitions.
Forbes Australia profiles Canva's enterprise relaunch after a demo with COO Cliff Obrecht, covering new sales, marketing and HR tools; Airtree's co-founder recalls the firm's early backing of the company.
EV charger maker Tritium DCFC has collapsed into administration, with KPMG appointees taking control of its Australian subsidiaries, after losses, a troubled US expansion, and a failed bid for Queensland government support.
Culture Amp is acquiring Orgnostic, a Belgrade-founded people analytics startup, for an undisclosed sum; its cofounders join as vice presidents and a combined People Analytics product is planned for later in 2024.
InterEarth, a Western Australian biomass carbon storage venture, has drawn investment from Fund WA — its third deal — alongside Counteract and Foxglove Capital, and is working with Nasdaq-owned carbon registry Puro.earth.
Coverage of Andrew Tate's deplatforming and his shift to Rumble, which then topped the app charts; the piece also notes the video platform's backers and its earlier stated plan to list on Nasdaq.
ASX-listed lender Wisr has added Cathryn Lyall, a veteran of exchanges and Deutsche Bank's UK board, as a non-executive director from January 2022, its second board addition in months.
Profile of Allbirds recounting its New Zealand origins, early grant and crowdfunding, seed and venture raises, key early hires, and its NASDAQ listing, crediting its sustainability mission for its rapid success.
ASX-listed drug developer ChemGenex will quit NASDAQ and SEC reporting to cut compliance costs, and three directors step down in July while staying on as advisers.
Australian drug developer Pharmaxis has won NASDAQ approval to trade its ADRs under ticker PXSLY, issuing no new shares; SEC registration is expected around 26 August 2005 before trading begins.
Also GBS Ventures·GBS Ventures